Genomics pioneer steps closer to dementia treatment breakthrough

An Icelandic scaleup has sparked hopes of a breakthrough in dementia treatment after raising €26.5mn for groundbreaking research. Arctic Therapeutics (ATx) attracted the investment after pioneering a new approach to drug development. Founded in 2015, the company first analyses genomic data with bioinformatics — a blend of computer science and biology. After identifying disease-associated genes and proteins, ATx targets the root causes of a given condition. According to the scaleup, t